Dexcom,Inc. (DXCM): Is the Pharma Stock Profitable?

Registered at 16.27% higher quarterly revenue of $811.79 million.  DXCM is trading premium at a Forward P/E ratio of 101.49. The next earning release is expected to be $0.26, with year-to-year gr...